Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Animal Genetics Market Size to Hit $8.21 Billion, Globally, by 2028 – Lead by Porcine Segment with 7% CAGR during (2022-2028) | The Insight Partners

Published

on

<!– Name:DistributionId Value:8784310 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2791 –> <!– Name:CustomerId Value:1214982 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:6253911b-0e25-4894-9030-f90160508cf1 –>

New York, March 08, 2023 (GLOBE NEWSWIRE) — According to The Insight Partners, “Animal Genetics Market Size, Share, Trends, Growth and Global Forecast to 2028 – COVID-19 Impact and Global Analysis by Products (Poultry, Porcine, Bovine, Canine, and Others); Genetic Material (Semen and Embryo); and Service (DNA Typing, Genetic Trait Tests, Genetic Disease Tests, and Others)”, the global animal genetics market size is expected to grow from USD 5.62 billion in 2022 to USD 8.21 billion by 2028; it is estimated to grow at a CAGR 5.9% during 2022-2028.

Download PDF Brochure at https://www.theinsightpartners.com/sample/TIPRE00003517

Global Animal Genetics Market – Report Scope:

Market Size Value in USD 5.62 Billion in 2022
Market Size Value by USD 8.21 Billion by 2028
Growth rate CAGR of 5.9% from 2022-2028
Forecast Period 2022-2028
Base Year 2022
No. of Pages 170
No. of Tables 83
No. of Charts & Figures 73
Historical data available Yes
Segments covered Products, Genetic Material, and Service

Global Animal Genetics Market: Competitive Landscape and Key Developments

Neogen Corporation, Genus, Groupe Grimaud, Topigs Norsvin, Zoetis Services Llc, Hendrix Genetics Bv, Envigo, Vetgen, Animal Genetics Inc, Alta Genetics Inc. are among the key companies operating in the animal genetics market. Leading players are adopting strategies such as expanding and diversifying their market presence and acquiring a new customer base to tap prevailing business opportunities.

In September 2020, Topigs Norsvin entered a strategic partnership with Acuity swine genetics company. This partnership will allow collaboration and expansion of technical expertise, commercial product testing, and supply chain infrastructure in the animal genetics market across the North American region.

In April 2020, Zoetis Animal Genetics and Angus Australia entered a strategic partnership that will aid Australian Angus breed stock and commercial breeders with an additional benefit from genomic or DNA-based technology. Zoetis has considerably expanded the Angus genomic reference population through genotyping services and sponsorship.

In October 2020, Hendrix Genetics and Solidaridad entered a partnership to provide sustainable poultry production in Mozambique and Zambia, Africa. Solidaridad is a local African poultry farming company that will have secured access to the poultry genetics technologies from Hendrix Genetics

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00003517

Rising Adoption of Progressive Genetic Practices Such as Artificial Insemination (AI) and Embryo Transfer to Drive Global Animal Genetics Market Growth during 2022-2028:

Growing focus on developing superior animal breeds using genetic engineering to obtain high reproduction rates for large-scale production of modified breeds is expected to drive the animal genetics market during the forecast period. Animal genetics emphasizes the inheritance and genetic variations in wild and domestic animals. This science is used commercially to test genetic disorders, test genetic traits, and type DNA. For identifying genetic hybridizations, animal genetics uses various genetic practices, such as artificial insemination, embryo transfer, and cytological studies. Moreover, artificial insemination (AI) can reduce various risks in animal breeding and disease transmission. It is found that female offspring cattle born through artificial insemination yield more milk than normal offspring. Additionally, the use of antibiotic-containing semen extensors is effective in preventing bacterial infectious diseases. Therefore, the entire AI process is considered more hygienic than natural mating.

The market players focus on partnerships, collaboration, and acquisitions to develop genetically modified breeds and maintain their market share. For instance, in August 2020, Cogent and AB Europe collaborated to launch a novel sexed semen service for sheep producers in the UK. In May 2018, Recombinetics entered into a partnership agreement with SEMEX to implement a precision breeding program, which is expected to improve animal health and well-being through hornless dairy cattle genetics. According to the Brazilian Association of Artificial Insemination, commercialized doses of semen increased from 7 million in 2003 to ~14 million in 2017. Thus, the rising adoption of genetic practices will support the animal genetics market growth in the coming years.

Check Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00003517

Global Animal Genetics Market – Segmentation Overview:

The animal genetics market, by product, is segmented into poultry, porcine, bovine, canine, and others. The porcine segment held the largest share of the animal genetics market in 2022, whereas the same segment is anticipated to register the highest CAGR of 7.0% during the forecast period. Pork is the most consumed meat across the globe. In the US, pork production generates US$23.4 billion in output annually. Additionally, 26% of that is around 2.2 million metric tons of pork, and its products are exported to other countries. Also, developments by the major pork producers in the country are likely to grow the pork production industry. For instance, in 2017, 123-year-old Clemens Food Group partnered with 12 independent hog farmers to establish a new packing plant in Michigan.

The animal genetics market, by genetic material, is segmented into semen and embryo. The embryo segment held the largest share of the animal genetics market in 2022, and the semen segment is anticipated to register the highest CAGR of 7.0% in the market during the forecast period. The accurate prediction of male fertility is of major economic importance in the animal breeding industry. Semen DNA tests are conducted to analyze the genotype on a semen-stained specimen. It also helps in animal breeding.

Based on service, the animal genetics market is segmented into DNA typing, genetic trait tests, genetic disease tests, and others. The DNA typing segment held the largest share of the animal genetics market in 2022. Also, the genetic disease tests segment is estimated to register the highest CAGR of 7.2% in the market during the forecast period.

Buy Premium Copy of Animal Genetics Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00003517

Browse other research published by The Insight Partners:

Global Genetic Testing Services Market Size to 2027 – Global Analysis and Forecasts by Type (Predictive Testing, Carrier Testing, Prenatal Testing, New-born Screening and Others), Disease (Cancer, Metabolic Diseases, Cardiovascular Diseases and Others), Service Provider (Diagnostic Laboratories, Hospital-Based Laboratories and Clinics) and Geography

Global Genetic Engineering Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology (CRISPR, TALEN, ZFN, Antisense, Other Technologies); Application (Cell line Engineering, Genetic Engineering, Diagnostics and Therapeutics); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations)

Global Genetic Analyzer Market Size Forecast to 2028 – Covid-19 Impact and Global Analysis – by Type (DNA Microarrays, PCR, Next Generation Sequencing, Serial Analysis of Gene Expression, Northern Blotting); Application (Diagnostics Centres, Drug Discovery, Research and Development, Others)

Global Genetic Toxicology Testing Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Reagents and Consumables, Assays, Services); End Use (Healthcare Industry (Pharmaceutical and Biotechnology), Food Industry, Cosmetics Industry, and Others), and Geography

Global Animal Health Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis by Product (Prescription and Non-Prescription) and Animal Type (Production Animal and Companion Animal)

Global Animal Vaccination Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines); Animal Type (Livestock animal, Companion Animals); Route of Administration (Oral, Parenteral, Others); Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, Others) and Geography

Global Animal Antibacterial And Antibiotics Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Tetracyclins, Penicilins, Sulfonamides, Macrolides, Quinolones, Amingoglycosides, Cephalosporins); Animals (Companion Animals, Food-Producing Animals); Mode of Delivery (Oral Powder or Solutions, Injections, Premix, Intramammary Preparations) and Geography

Global Farm Animal Drugs Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type (Anti-Infective, Parasiticides, Anti-Inflammatory, Anesthetics, Analgesics, Hormones and Related Product, and Others), Animal Type (Livestock Animal and Equine), Route of Administration (Oral, Parenteral, Topical, and Others), and Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores, and Others), and Geography

Global Veterinary Medicine Market Size Forecast to 2028 – Covid-19 Impact and Global Analysis – by Product (Drugs, Vaccines, Medicated Feed Additives); Route of administration (Oral, Parenteral, Topical); Animal Type (Companion Animals, Livestock Animals); End-user (Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug Stores), and Geography

Global Animal Protein Market Size Forecast to 2028 – COVID-19 Impact and Global Analysis By Source (Egg, Dairy, Others); Form (Solid, Liquid); Application (Food and beverages, Pharmaceuticals and nutraceuticals, Personal Care, Animal feed) and Geography

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/animal-genetics-market

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading

Trending